BLOG
WAT Medical’s EmeTerm Wearable Device Demonstra...
VANCOUVER, BC, February 9th, 2026 /PRNewswire/ — WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world’s most reputable and...
WAT Medical’s EmeTerm Wearable Device Demonstra...
VANCOUVER, BC, February 9th, 2026 /PRNewswire/ — WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world’s most reputable and...
2025 Carbon Neutrality & Sustainability Report
Introduction At WAT Medical, sustainability is integrated into the full lifecycle of our non-drug neuromodulation solutions, including EmeTerm for nausea relief and HeadaTerm for migraine management. We believe that true...
2025 Carbon Neutrality & Sustainability Report
Introduction At WAT Medical, sustainability is integrated into the full lifecycle of our non-drug neuromodulation solutions, including EmeTerm for nausea relief and HeadaTerm for migraine management. We believe that true...
EmeTerm Wristband Significantly Reduction in Po...
VANCOUVER, BC, November 3rd, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits...
EmeTerm Wristband Significantly Reduction in Po...
VANCOUVER, BC, November 3rd, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits...
EmeTerm Wearable Device Under Clinical Study at...
VANCOUVER, BC, September 15, 2025 /PRNewswire/ – WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among...
EmeTerm Wearable Device Under Clinical Study at...
VANCOUVER, BC, September 15, 2025 /PRNewswire/ – WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among...
American Migraine Foundation Highlights HeadaTe...
VANCOUVER, BC, June 16, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. is pleased to announce that its migraine relief device, HeadaTerm 2, is now featured on the American Migraine Foundation’s (AMF)...
American Migraine Foundation Highlights HeadaTe...
VANCOUVER, BC, June 16, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. is pleased to announce that its migraine relief device, HeadaTerm 2, is now featured on the American Migraine Foundation’s (AMF)...
Neuromodulation Wristband ObeEnd Reduces Heart ...
VANCOUVER, BC, Jan.13, 2025 /PRNewswire/ —WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the neuromodulation device designed for weight and health management. The study revealed...
Neuromodulation Wristband ObeEnd Reduces Heart ...
VANCOUVER, BC, Jan.13, 2025 /PRNewswire/ —WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the neuromodulation device designed for weight and health management. The study revealed...